At close: 9:31:33 AM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CLAUSEN PETER Chief Operating Officer | Stock Award(Grant) | May 20, 2024 | 589,675 |
| PITTMAN SCOTT M Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Nov 15, 2024 | 5,396,050 |
| SHEEDY CHARLES E Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 18, 2024 | 11,440,900 |
Related Tickers
ESLAW Estrella Immunopharma, Inc.
0.0910
-0.11%
SBMFF Sino Biopharmaceutical Limited
0.4110
0.00%
INTI Inhibitor Therapeutics, Inc.
0.0600
0.00%
MBXBF Microbix Biosystems Inc.
0.2900
-3.62%
MRES Institute of Biomedical Research Corp.
0.0247
+87.12%
ACHFF Arch Biopartners Inc.
1.3300
0.00%
EMMA Emmaus Life Sciences, Inc.
0.0140
0.00%
KRBP Kiromic BioPharma, Inc.
0.9250
0.00%
ESLA Estrella Immunopharma, Inc.
1.1900
+6.25%
ATNFW 180 Life Sciences Corp.
0.0100
-4.76%